Details

Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults, CCDR 51(2/3) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 18, 2025 · edition #1
Timestamp: 2025-04-18T21:40:12.111Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2025-51/issue-2-3-february-march-2025/cost-effectiveness-21-valent-pneumococcal-conjugate-vaccine-adults.html?wbdisable=false
Replay URL: https://replay.healtharchive.ca/job-1/20250418214012/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2025-51/issue-2-3-february-march-2025/cost-effectiveness-21-valent-pneumococcal-conjugate-vaccine-adults.html?wbdisable=false#ha_snapshot=167924
ID: 167924
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots